The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|1|1|11-17

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.1, Iss.1, 2001-05, pp. : 11-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structured treatment interruptions in HIV infection

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cytokine therapy or structured treatment interruptions in HIV infection: which is best?

By Parienti Jean-Jacques  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 719-726

Informa Healthcare

Access to resources Recommend Favorite

Structured treatment interruption strategy effective for HIV infection

By  

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Treatment Strategy Issues for Chronic HIV-1 Infection in Adults: The Dilemma of Life-long Antiretroviral Treatment

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 1, 2005-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Structured Treatment Interruption in Patients Infected with HIV: A New Approach to Therapy

By Gulick R.M.  

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 245-253

Adis International

Access to resources Recommend Favorite